Status:

COMPLETED

Using an Interactive Game to Reduce Fear and Increase Spine Motion in Low Back Pain

Lead Sponsor:

Ohio University

Conditions:

Low Back Pain

Eligibility:

All Genders

18-50 years

Phase:

NA

Brief Summary

A fundamental clinical problem in individuals with chronic low back pain is the significant alteration in movement patterns that restrict lumbar spine motion. This is particularly true for individuals...

Detailed Description

Using a 2 groups (Game, Control) between subjects design, the investigators will assess the influence of participation in a computer game of virtual dodge ball that requires whole-body reaching moveme...

Eligibility Criteria

Inclusion

  • Answer Yes to the following:
  • Have you had low back pain constantly or on most days for the last 3 months?
  • Has your back pain caused you to seek medical care?
  • Low back pain is classified from category 1 (back pain that does not radiate) through category 3 (back pain that radiates beyond the knee, but without neurological signs) on the Classification System of the Quebec Task Force on Spinal Disorders.
  • Report elevated levels of kinesiophobia.
  • Report no health conditions that may restrict movement or preclude safe participation.

Exclusion

  • Individuals must not:
  • Have a personal history of the following neurological disorders: Alzheimer's, Amyotrophic Lateral Sclerosis, Multiple Sclerosis, Parkinson's, Stroke
  • Have a personal history of the following cardiorespiratory disorders: Congestive heart failure, Heart attack in past 24 months
  • Have a personal history of the following musculoskeletal disorders: Rheumatoid Arthritis, pathologic fractures of the spine, avascular necrosis or osteonecrosis, severe osteoarthritis.
  • Have a personal history of spine surgery or a hip arthroplasty
  • Have active cancer or recent, unexplained weight loss
  • Report being blind
  • Report being pregnant
  • Report current or pending litigation related to back pain
  • Currently be taking narcotic medication
  • Score in the clinically significant range for substance abuse (Drug Abuse Screening Test (DAST) \> 6), alcohol abuse (Alcohol Use Disorders Identification Test (AUDIT-C) \> 4), or depression (Center for Epidemiological Studies-Depression (CES-D) \> 16).

Key Trial Info

Start Date :

January 1 2015

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2016

Estimated Enrollment :

53 Patients enrolled

Trial Details

Trial ID

NCT02301741

Start Date

January 1 2015

End Date

April 1 2016

Last Update

June 13 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ohio University

Athens, Ohio, United States, 45701